Long-term changes in striatal opioid systems after 6-hydroxydopamine lesion of rat substantia nigra
- PMID: 8232904
- DOI: 10.1016/0306-4522(93)90309-4
Long-term changes in striatal opioid systems after 6-hydroxydopamine lesion of rat substantia nigra
Abstract
The effects of unilateral 6-hydroxydopamine lesion of the nigrostriatal pathway on striatal opioid peptides and receptors were determined at different time-intervals, from three days up to 24 weeks, post-lesion. Mu, delta and kappa opioid binding site densities in the ipsilateral caudate-putamen were decreased by 25-50% in rats which exhibited a greater than 90% loss of dopamine uptake sites. Differentiation of radioligand binding to kappa1 and kappa2 subtypes demonstrated a selective loss of kappa2 sites post-lesion. The onset of significant 6-hydroxydopamine lesion-induced changes in striatal opioid binding sites was delayed with respect to the loss of dopamine uptake sites. Furthermore, maximal loss of dopamine uptake sites was apparent within seven days post-lesion, but not until two to four weeks for mu, delta and kappa sites. In animals which exhibited an incomplete loss of dopamine uptake sites (less than 80%) there was no significant change in opioid binding site density. Striatal proenkephalin and prodynorphin messenger RNA levels were increased and decreased, respectively, after complete 6-hydroxydopamine lesion. Modulation of peptide messenger RNA levels was apparent within seven days and was maintained up to 24 weeks post-lesion. In contrast, proenkephalin and prodynorphin messenger RNA levels were unchanged in animals which exhibited an incomplete loss of striatal dopamine uptake sites. Taken together, these observations suggest that the majority of mu, delta and kappa2 opioid binding sites are localized on non-dopaminergic elements in the caudate-putamen, but that substantia nigra innervation plays a role in the control of striatal opioid receptor expression. The 6-hydroxydopamine lesion-induced decreases in striatal opioid binding site density may, in part, be a function of agonist-induced receptor downregulation. Alternatively, both opioid receptor and peptide expression in the caudate-putamen may be directly, but independently, regulated by ventral mesencephalic neurons.
Similar articles
-
Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.Neuroscience. 2000;95(2):377-88. doi: 10.1016/s0306-4522(99)00457-1. Neuroscience. 2000. PMID: 10658617
-
Effect of brain lesions on [3H]ohmefentanyl binding site densities in the rat striatum and substantia nigra.Chem Pharm Bull (Tokyo). 1992 Sep;40(9):2520-4. doi: 10.1248/cpb.40.2520. Chem Pharm Bull (Tokyo). 1992. PMID: 1332831
-
Localization of striatal opioid gene expression, and its modulation by the mesostriatal dopamine pathway: an in situ hybridization study.J Mol Neurosci. 1989;1(1):9-18. doi: 10.1007/BF02896851. J Mol Neurosci. 1989. PMID: 2561993
-
Postnatal development of functional dopamine, opioid and tachykinin receptors that regulate acetylcholine release from rat neostriatal slices. Effect of 6-hydroxydopamine lesion.Int J Dev Neurosci. 1993 Dec;11(6):701-8. doi: 10.1016/0736-5748(93)90059-m. Int J Dev Neurosci. 1993. PMID: 8135128 Review.
-
Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae.Prog Neurobiol. 1996 Jun;49(3):215-66. doi: 10.1016/s0301-0082(96)00015-9. Prog Neurobiol. 1996. PMID: 8878304 Review.
Cited by
-
Kainic acid modifies mu-receptor binding in young, adult, and elderly rat brain.Cell Mol Neurobiol. 2002 Dec;22(5-6):741-53. doi: 10.1023/a:1021861108885. Cell Mol Neurobiol. 2002. PMID: 12585692 Free PMC article.
-
Response of striosomal opioid signaling to dopamine depletion in 6-hydroxydopamine-lesioned rat model of Parkinson's disease: a potential compensatory role.Front Cell Neurosci. 2013 May 17;7:74. doi: 10.3389/fncel.2013.00074. eCollection 2013. Front Cell Neurosci. 2013. PMID: 23730270 Free PMC article.
-
Characterization of the decrease of extracellular striatal dopamine induced by intrastriatal morphine administration.Br J Pharmacol. 1999 May;127(1):268-74. doi: 10.1038/sj.bjp.0702542. Br J Pharmacol. 1999. PMID: 10369482 Free PMC article.
-
Striatal output markers do not alter in response to circling behaviour in 6-OHDA lesioned rats produced by acute or chronic administration of the monoamine uptake inhibitor BTS 74 398.J Neural Transm (Vienna). 2008;115(3):423-9. doi: 10.1007/s00702-007-0854-x. Epub 2008 Feb 4. J Neural Transm (Vienna). 2008. PMID: 18250952
-
Morphine and naltrexone modulate D2 but not D1 receptor induced motor behavior in MPTP-lesioned monkeys.Psychopharmacology (Berl). 1995 Apr;118(4):451-9. doi: 10.1007/BF02245946. Psychopharmacology (Berl). 1995. PMID: 7568632
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials